AV-001
- Generic Name
- AV-001
A First-in-Human Study of AV-001 in Healthy Subjects
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Vasomune Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04737486
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath